BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017 BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology ...
This release is available in Chinese. Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had ...
"Our goal was to demonstrate that auto-programming provides an additional layer of safety than the stand-alone technologies and by streamlining the IV medication ...
VALENCIA, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- PDC, a global leader of innovative identification and patient safety solutions, announced today the launch of Ident-Alert® IV Port Clips for ...
To ensure safety throughout the supply chain and in the patient’s home, providers are adopting tamper-evident products for intravenous home infusion. To better understand the steps home infusion ...
Ten of the 60 cytotoxic products on the market contained ethanol at concentrations of up to 790 mg/mL, depending on the drug, formulation, and supplier. Several final preparations contained more than ...
Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer ...
The subcutaneous formulation of toripalimab demonstrated noninferior pharmacokinetics compared to the intravenous version in ...
On May 15, 2025, the State Medical Board of Ohio, the Ohio Board of Pharmacy and the Ohio Board of Nursing (collectively, the “Boards”) jointly issued a significant regulatory statement (the ...
Eisai files for Japan approval of a weekly at-home Leqembi injection, offering an alternative to IV dosing and aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback